# Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)

> **NCT02114775** · PHASE1 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 34 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Growth Hormone
- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02114775
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-12
- **Primary completion:** 2017-11-10
- **Final completion:** 2017-11-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114775, "Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02114775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*